Clean up drug approvals
What do many pharmaceutical companies across the world do when the number of new molecules that get past human clinical trials and the regulatory approval process is in steady decline?
Related Content
- Bangladesh State of Environment Report: The Monthly Overview, April 2014
- Bhutan State of Environment Report: The Monthly Overview, March, 2014
- India State of the Environment Report : The Monthly Overview, September 2013
- Lens on Ethics Panels for Clinical Tests
- Costly vaccine to pre empt cervical cancer may not find takers
- MONEYMAKERS